|
The fertile minds at Merck Serono help people around the world combat infertility. One of the world's top biotechs, Merck Serono focuses on recombinant genetic engineering to develop drugs. The firm manufactures and markets therapies for neurological, metabolic, endocrinology, oncology, cardiovascular, and growth disorders, among others. It is a leader in reproductive health; flagship drug Gonal-F is a leading infertility product line. Other key products include beta interferon drug Rebif for the treatment of multiple sclerosis (MS) and colorectal and head/neck cancer treatment Erbitux. The company is German drugmaker Merck KGaA's largest subsidiary, responsible for its pharmaceutical research.
|
| | | Contact Information | |
Address: |
9, chemin des Mines
1211 Geneva 20, Switzerland
| | Phone: | +41-22-414-3000 | | Fax: | +41-22-414-2179 |
|
| Financial
Highlights | | Fiscal Year End: | December |
|
|
Key People
| | • |
President:
Stefan Oschmann
| | • |
COO:
Belén Garijo
| | • |
SVP Divisional Controlling:
Dorothea Wenzel
|
|
|
Industry Information
| |
Sector: | |
Industry: |
|
|
